President Donald Trump’s fiscal 2020 budget again calls for giving the Health Resources and Services Administration more authority over the 340B program, creating a user-fee program and tying Medicare reimbursement for 340B drugs to hospitals’ uncompensated care percentages. The president’s overall budget also indicates the agency is again looking at eligibility standards for 340B, as it asks for “broad regulatory authority for the 340B Drug Pricing Program to set enforceable standards of program participation.” HRSA, in its fiscal 2019 budget...